Navigation Links
ALEVE-D(R) Sinus & Cold Offers Option for the More Than 50% of Consumers Not Satisfied with Current Sinus Medication
Date:10/22/2007

MORRISTOWN, N.J., Oct. 22 /PRNewswire/ -- Bayer Consumer Care announces the availability of the newly-named ALEVE-D(R) Sinus and Cold (formerly ALEVE Cold and Sinus), combining a long-lasting nasal decongestant with the pain-relieving power of ALEVE (naproxen sodium) for all-day relief from multiple sinus and pain symptoms.

The combination of ingredients in ALEVE-D address consumer concerns as identified in a recent survey of adults who suffer from sinus symptoms. More than half of those polled (56 percent) say they are not completely satisfied with their current sinus medication, reporting that their medication does not last long enough (65 percent) and that they need more than one product to completely relieve their symptoms (62 percent). The symptoms most commonly experienced by those surveyed are stuffy nose or nasal congestion (89 percent), sinus congestion (78 percent) and headache (73 percent).

The active ingredients in ALEVE-D, pseudoephedrine (PSE) and naproxen sodium combine to provide 12 hours of relief from symptoms including sinus pressure, headache, and nasal and sinus congestion.

"Consumers rely on the ALEVE family of products for long-lasting relief," said Jay Kolpon, Vice President, Marketing and New Business Development, Bayer Consumer Care. "With ALEVE-D, we are offering consumers the power of ALEVE combined with the proven effectiveness of pseudoephedrine in one pill that provides 12 hours of relief from sinus and pain symptoms."

Each ALEVE-D caplet contains naproxen sodium (220mg) and PSE HCL (120mg). Adults and children 12 years and older may take one caplet every eight to 12 hours while symptoms last, and should not exceed two capsules in a 24-hour period. ALEVE-D is available exclusively behind the pharmacy counter without a prescription.

For more information, visit http://www.AleveD.com.

About ALEVE and ALEVE-D

Since its introduction as an OTC product in June 1994, ALEVE has been used by millions of Americans as a safe and effective pain reliever for more than a decade. With the convenience of all day relief with just one pill, ALEVE-D temporarily relieves cold, sinus and flu symptoms including sinus pressure, minor body aches and pains, headache, nasal and sinus congestion (promotes sinus drainage and restores freer breathing through the nose) and fever. Always read and follow label instructions.

About Bayer Consumer Care

The Consumer Care Division of Bayer HealthCare LLC, is headquartered in Morristown, N.J. Bayer's Consumer Care Division is among the largest marketers of over-the-counter medications and nutritional supplements in the world. Some of the most trusted and recognizable brands in the world today come from the Bayer portfolio of products. These include Bayer(R) Aspirin, ALEVE(R), Alka-Seltzer Plus(R), Bactine(R), RID(R), Phillips'(R) Milk of Magnesia, Midol(R), Alka-Seltzer(R), One-A-Day(R) multivitamins and Flintstones(TM) vitamins.

Bayer Corporation, headquartered in Pittsburgh, is a subsidiary of Bayer AG, an international health care, nutrition and innovative materials group based in Leverkusen, Germany. In North America, Bayer had 2006 net sales of 7.8 billion euros and employed 17,200 at year end. Bayer's three subgroups, Bayer HealthCare, Bayer CropScience and Bayer MaterialScience, improve people's lives through a broad range of essential products that help prevent and treat diseases; protect crops and enhance yields; and advance automobile safety and durability.

About the Survey

This survey was conducted by The Segmentation Company, a division of Yankelovich. These results were based on a telephone survey conducted between August 9-12, 2007, among a sample of 675 Americans age 18 and older who suffer from sinus symptoms. For results based on the total sample, the margin of error is plus or minus 3.8 percentage points. For results based on smaller sub samples, the margin of error is larger.


'/>"/>
SOURCE Bayer Consumer Care
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Cost-effective antibiotics for sinusitis treatment
2. Humming helps sinusitis
3. Chronic Fatigue, Pain Linked to Sinusitis
4. Asthma Patients With Sinusitis More Difficult To Treat
5. Drug Resistance Questioned in Patients With Chronic Sinusitis
6. Chronic Sinusitis May Be Related To Nasal Mucus
7. Children With Sinusitis Lead A Better Life After Surgery
8. Age Can Changes Symptoms Of Sinusitis
9. Novel Technique For Management Of Inverted Papilloma Of Frontal Sinus
10. Immune Response Linked to “Ghost” Parasites and Severely Congested Sinuss
11. Chronic Sinusitis Resulting From Weakene Immune System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/25/2017)... ... , ... Norland at Swissray is pleased to announce the release of the ELITE ... DXA has an active scan window, which is more than double that of existing bone ... area could not undergo an accurate total body bone density or body composition study. ...
(Date:3/24/2017)... ... March 24, 2017 , ... Mediaplanet today announces distribution of ... current obstacles facing infection prevention and offer strategies for the health care community ... , The print component of “Fighting Infection” is distributed within the Friday, ...
(Date:3/24/2017)... ... 24, 2017 , ... The Radiology Business Management Association (RBMA) has ... now in their 12th year, are among the most prestigious in radiology marketing because ... awards were retooled to recognize achievements in both large budget (over $5,000) and small ...
(Date:3/24/2017)... ... March 24, 2017 , ... The iaedp Foundation, the premier provider of educational ... those suffering from the full spectrum of disordered eating, announced today that the 2017 ... nearly all 50 states and several countries converged on the Green Valley Resort in ...
(Date:3/24/2017)... ... March 24, 2017 , ... In just ... EcoQube Frame vertical micro-veggies garden on Kickstarter . Surpassing the $100,000 milestone ... with nearly 2,000 consumers (and counting) already backing the campaign. , “We ...
Breaking Medicine News(10 mins):
(Date:3/24/2017)... 2017 Research and Markets has announced the addition ... report to their offering. ... The IPF pipeline is very strong with a total of 97 drug ... Biogen and Sanofi are involved in the development of the IPF therapeutics. ... in Phase III stage, 15 are in Phase II stage, 12 are ...
(Date:3/24/2017)... A ReportsnReports.com report says, over the recent ... the global sales of Adcetris and Kadcyla have been witnessing rapid ... conjugates market is driven by large number of ADC drugs in ... offered by ADCs. ... Browse 3 Tables and 94 Figures, 10 Major Company Profiles, spread ...
(Date:3/24/2017)... March 24, 2017 Today Stock-Callers.com have ... which are: Neovasc Inc. (NASDAQ: NVCN), Hologic Inc. (NASDAQ: HOLX), ... SSH ). These companies are part of the ... on Thursday, March 23 rd , 2017, with the NYSE ... of health care companies in the S&P 500 were down ...
Breaking Medicine Technology: